Freeze and boost: new combo aims to stop Triple-Negative breast cancer return
NCT ID NCT03546686
First seen Oct 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study is for women with early-stage triple-negative breast cancer who still have tumor after initial chemotherapy. Researchers are testing a combination of a freezing treatment (cryoablation) and an immunotherapy drug given before surgery. The goal is to see if this approach can lower the chance of the cancer coming back over three years. About 51 women will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Ohio State University Medical Center
Columbus, Ohio, 43210, United States
-
Providence Cancer Institute
Portland, Oregon, 97213, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.